Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL

Bibliographic Details
Published in:Leukemia
Main Authors: Howard, D R, Munir, T, McParland, L, Rawstron, A C, Milligan, D, Schuh, A, Hockaday, A, Allsup, D J, Marshall, S, Duncombe, A S, O'Dwyer, J L, Smith, A F, Longo, R, Varghese, A, Hillmen, P
Format: Article in Journal/Newspaper
Language:English
Published: Springer Science and Business Media LLC 2017
Subjects:
Oncology
Cancer Research
Hematology
Arctic
Online Access:http://dx.doi.org/10.1038/leu.2017.96
https://www.nature.com/articles/leu201796.pdf
https://www.nature.com/articles/leu201796
http://www.nature.com/doifinder/10.1038/leu.2017.96
id crspringernat:10.1038/leu.2017.96
record_format openpolar
spelling crspringernat:10.1038/leu.2017.96 2023-05-15T14:43:01+02:00 Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL Howard, D R Munir, T McParland, L Rawstron, A C Milligan, D Schuh, A Hockaday, A Allsup, D J Marshall, S Duncombe, A S O'Dwyer, J L Smith, A F Longo, R Varghese, A Hillmen, P 2017 http://dx.doi.org/10.1038/leu.2017.96 https://www.nature.com/articles/leu201796.pdf https://www.nature.com/articles/leu201796 http://www.nature.com/doifinder/10.1038/leu.2017.96 en eng Springer Science and Business Media LLC https://www.springer.com/tdm https://www.springer.com/tdm Leukemia volume 31, issue 11, page 2416-2425 ISSN 0887-6924 1476-5551 Oncology Cancer Research Hematology journal-article 2017 crspringernat https://doi.org/10.1038/leu.2017.96 2022-01-04T16:41:52Z Article in Journal/Newspaper Arctic Springer Nature (via Crossref) Arctic Leukemia 31 11 2416 2425
institution Open Polar
collection Springer Nature (via Crossref)
op_collection_id crspringernat
language English
topic Oncology
Cancer Research
Hematology
spellingShingle Oncology
Cancer Research
Hematology
Howard, D R
Munir, T
McParland, L
Rawstron, A C
Milligan, D
Schuh, A
Hockaday, A
Allsup, D J
Marshall, S
Duncombe, A S
O'Dwyer, J L
Smith, A F
Longo, R
Varghese, A
Hillmen, P
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL
topic_facet Oncology
Cancer Research
Hematology
format Article in Journal/Newspaper
author Howard, D R
Munir, T
McParland, L
Rawstron, A C
Milligan, D
Schuh, A
Hockaday, A
Allsup, D J
Marshall, S
Duncombe, A S
O'Dwyer, J L
Smith, A F
Longo, R
Varghese, A
Hillmen, P
author_facet Howard, D R
Munir, T
McParland, L
Rawstron, A C
Milligan, D
Schuh, A
Hockaday, A
Allsup, D J
Marshall, S
Duncombe, A S
O'Dwyer, J L
Smith, A F
Longo, R
Varghese, A
Hillmen, P
author_sort Howard, D R
title Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL
title_short Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL
title_full Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL
title_fullStr Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL
title_full_unstemmed Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL
title_sort results of the randomized phase iib arctic trial of low-dose rituximab in previously untreated cll
publisher Springer Science and Business Media LLC
publishDate 2017
url http://dx.doi.org/10.1038/leu.2017.96
https://www.nature.com/articles/leu201796.pdf
https://www.nature.com/articles/leu201796
http://www.nature.com/doifinder/10.1038/leu.2017.96
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Leukemia
volume 31, issue 11, page 2416-2425
ISSN 0887-6924 1476-5551
op_rights https://www.springer.com/tdm
https://www.springer.com/tdm
op_doi https://doi.org/10.1038/leu.2017.96
container_title Leukemia
container_volume 31
container_issue 11
container_start_page 2416
op_container_end_page 2425
_version_ 1766314708940357632

Similar Items